MKRN1 degrades AGC1 to trigger chemotherapy resistance of colorectal Cancer
Abstract Oxaliplatin (Oxa) has been extensively employed in treatment of colorectal cancer (CRC), yet frequent occurrence of chemoresistance poses a significant obstacle to achieving long-term disease-free survival for CRC patients. In this study, we employed a CRISPR/Cas9 sgRNA library targeting 1,...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-07-01
|
| Schriftenreihe: | Molecular Medicine |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s10020-025-01287-2 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
